Latest / Stock Movers / Coreweave Mixed, Hims & Hers Dips, Trade Desk Falls With Outlook Still in Question
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios. Podcasts. Radio.
- 0:06Speaker 2: News.
- 0:08Speaker 1: The Stock Movers Report. Your roundup of companies making moves
- 0:12Speaker 1: in the stock market. Harnessing the power of Bloomberg data.
- 0:15Speaker 2: Let's take a look at some individual stocks on the
- 0:18Speaker 2: move today. And we can do that with Anne Guillen,
- 0:20Speaker 2: Bloomberg Earnings Reporter.
- 0:22Speaker 1: Anne, what are you looking at today?
- 0:23Speaker 2: Today, I am looking at CoreWeave. That's ticker C-R-W-V-E. It's
- 0:29Speaker 2: been mixed this morning but was up as much as 3%,
- 0:32Speaker 2: and that is before they report earnings after the bell today.
- 0:36Speaker 2: And I think more than just the quarterly result, investors
- 0:41Speaker 2: are really focused on what core use management will say
- 0:44Speaker 2: comes next for them in light of the midterm elections
- 0:47Speaker 2: last week after several candidates that have pledged to slow
- 0:51Speaker 2: or block earnings. data center development won their races and
- 0:54Speaker 2: also the NVIDIA situation. CoreWeave obviously has a very close
- 0:59Speaker 2: relationship with NVIDIA. So I think investors are really looking
- 1:02Speaker 2: at those two kind of more long-term factors and what
- 1:06Speaker 2: it means for CoreWeave. Okay, so Court Weave, due to
- 1:09Speaker 2: report earnings, you're also focused on earnings when it comes
- 1:11Speaker 2: to another name. Yes, I'm looking at HIMS and HERS,
- 1:14Speaker 2: which is ticker H-I-M-S. They reported last night, and HIMS
- 1:18Speaker 2: shares are down more than 14% this morning, and that
- 1:22Speaker 2: is after they cut their full-year EBITDA guide for the
- 1:26Speaker 2: third time in a row and gave revenue and adjusted
- 1:31Speaker 2: EBITDA numbers for the fourth quarter that were short of analysts' expectations.
- 1:35Speaker 2: HIMSS has been kind of trying to pivot away from
- 1:38Speaker 2: the original compounded GLP-1s that really helped them grow their business.
- 1:42Speaker 2: They've been striking deals with drug makers to sell those
- 1:46Speaker 2: branded drugs directly. And so I think investors are still
- 1:49Speaker 2: a little bit unclear, again, on what the longer term
- 1:52Speaker 2: picture for HIMSS is and how those deals kind of
- 1:55Speaker 2: affect their business model going forward. Okay, one more.
- 1:58Speaker 1: Where do you go?
- 1:59Speaker 2: One more is the trade desk, that's ticker TTD. Trade
- 2:03Speaker 2: desk shares are down as much as 2% this morning.
- 2:07Speaker 2: but those shares are down more than 60% so far
- 2:10Speaker 2: this year. That is after their third quarter results beat expectations,
- 2:14Speaker 2: but analysts are still unclear about the outlook for the
- 2:18Speaker 2: company going forward. The Trade Desk has had a rough year.
- 2:21Speaker 2: As I mentioned, those shares are down quite a bit
- 2:23Speaker 2: so far this year. There's been lots of executive departures,
- 2:26Speaker 2: lots of questions about, you know, the Trade Desk is
- 2:29Speaker 2: an advertising technology company. Where does that fit in, you know,
- 2:33Speaker 2: in the longer term as AI adoption grows? And, you know,
- 2:37Speaker 2: humans aren't necessarily looking at as many ads. So lots
- 2:41Speaker 2: of longer term questions there as well for investors.
- 2:45Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 2:49Speaker 1: us throughout the day for the latest roundup of companies
- 2:52Speaker 1: making news on Wall Street and for the latest market
- 2:55Speaker 1: moving headlines. Listen to Bloomberg Radio live. Catch us on YouTube,
- 3:00Speaker 1: Bloomberg.com and on Apple CarPlay and Android Auto with the
- 3:03Speaker 1: Bloomberg Business app.